Bronchiectasis
Understanding Bronchiectasis: Find information on diagnosis, treatment, and management of this chronic bronchial dilation, also known as bronchial dilatation. This resource covers clinical documentation, medical coding, healthcare guidelines, and best practices for Bronchiectasis (ICD-10 J47), supporting accurate and efficient patient care. Learn about symptoms, causes, and the latest research related to Bronchiectasis.
Irreversible widening of the bronchi, leading to mucus buildup and recurrent infections.
Persistent cough with thick mucus, shortness of breath, wheezing, and repeated chest infections.
Outpatient pulmonology clinics, hospitals for acute exacerbations, and imaging centers.
ICD-10 Code Families
Complete code families applicable to J47.9
When to use each related code
| Description | When to use |
|---|---|
| Irreversible bronchial dilation with mucus buildup. | Code B Bronchiectasis when imaging confirms permanently dilated airways due to chronic infection or inflammation. |
| Inflammation of the bronchi, often following a viral infection. | Use Acute Bronchitis for short-term inflammation without permanent dilation. Consider viral or bacterial etiology. |
| Progressive lung disease obstructing airflow, often with chronic bronchitis component. | Code COPD for chronic airflow limitation with dyspnea, cough, sputum production. Bronchiectasis can be a comorbidity. |
Best-practice checklist
- ✓Document bronchiectasis symptom onset and duration.
- ✓Specify bronchiectasis type (e.g., cylindrical, varicose, cystic).
- ✓Note any underlying causes or associated conditions.
- ✓Record severity (mild, moderate, severe) with supporting evidence.
- ✓Include imaging results confirming bronchial dilation.
Common pitfalls to avoid
Coding for unspecified bronchiectasis (J47.9) when clinical documentation supports a more specific type (e.g., post-infectious, J47.0).
Miscoding acute exacerbations of bronchiectasis as acute bronchitis (J20.9) leading to inaccurate severity reflection.
Failure to code associated conditions like COPD or cystic fibrosis, impacting reimbursement and quality metrics.
Best-practice tips
- 01Document sputum culture results for accurate Bronchiectasis coding (ICD-10-CM J47)
- 02Regularly assess lung function with spirometry for optimal CDI of Bronchiectasis severity
- 03Ensure antibiotic therapy aligns with documented pathogen for compliance with treatment guidelines
- 04Clearly differentiate Bronchiectasis from other COPD in clinical notes for proper reimbursement
- 05Monitor and document patient response to airway clearance techniques for improved healthcare outcomes
Step-by-step checklist
- 1
Verify persistent cough with sputum production (ICD-10 J47, SNOMED CT 87600008)
- 2
Confirm dilated airways on CT scan (ICD-10 R91.8, SNOMED CT 129088005)
- 3
Exclude alternative diagnoses like cystic fibrosis, COPD (SNOMED CT 223536001, 13645005)
- 4
Document symptom duration and frequency for accurate coding (HCC 111)
- 5
Assess for exacerbations and consider antibiotic treatment (SNOMED CT 441740008)
Ready-to-paste narrative
Patient presents with chronic productive cough, a hallmark symptom of bronchiectasis. The patient reports copious sputum production, often purulent, and experiences frequent exacerbations characterized by increased cough, dyspnea, and fatigue. Physical examination reveals crackles and wheezing on auscultation. Pulmonary function testing demonstrates an obstructive ventilatory defect. High-resolution computed tomography (HRCT) of the chest, the gold standard for diagnosis, confirms the presence of dilated bronchi with characteristic signet ring sign and tram-track appearance, consistent with a diagnosis of bronchiectasis. Differential diagnoses considered included cystic fibrosis, primary ciliary dyskinesia, and allergic bronchopulmonary aspergillosis. Given the patient's history, physical exam findings, and imaging results, the diagnosis of bronchiectasis is established. The patient's symptoms and imaging findings do not suggest an acute exacerbation at this time. Treatment plan includes airway clearance techniques such as chest physiotherapy and postural drainage, along with inhaled bronchodilators and mucolytics to manage secretions and improve lung function. Patient education regarding pulmonary hygiene and the importance of regular follow-up care was provided. ICD-10 code J47.0, Bronchiectasis, is documented for medical billing and coding purposes. The patient will be monitored for treatment response and potential complications, including recurrent infections and respiratory failure. Further investigations may be considered to determine the underlying etiology of the bronchiectasis.
Common questions and answers
What are the most effective diagnostic approaches for differentiating bronchiectasis from other chronic respiratory conditions like COPD and asthma in adults?+
Differentiating bronchiectasis from COPD and asthma requires a multifaceted approach. High-resolution computed tomography (HRCT) of the chest is the gold standard for diagnosing bronchiectasis, revealing characteristic bronchial wall thickening and airway dilation. While pulmonary function tests (PFTs) can show obstructive patterns in both bronchiectasis and COPD, they are not specific to bronchiectasis. However, PFTs can help assess the severity of airflow limitation. Unlike asthma, bronchiectasis is irreversible and typically doesn't respond significantly to bronchodilators. Clinical history, including recurrent infections, chronic cough with copious sputum production, and hemoptysis, can further distinguish bronchiectasis. Consider implementing a comprehensive diagnostic strategy incorporating imaging, PFTs, and clinical presentation for accurate diagnosis and personalized management. Explore how S10.AI can streamline your diagnostic process for bronchiectasis and other respiratory conditions.
How can I effectively manage acute exacerbations of bronchiectasis in patients with comorbidities like diabetes and heart failure?+
Managing acute exacerbations of bronchiectasis in patients with comorbidities necessitates a careful, individualized approach. Treatment focuses on controlling infection with appropriate antibiotics, often guided by sputum culture and sensitivity. In patients with diabetes and heart failure, it is essential to consider potential drug interactions and adjust medications accordingly. Optimize airway clearance techniques, such as chest physiotherapy and postural drainage, to facilitate sputum expectoration. Closely monitor blood glucose levels in diabetic patients and address any signs of heart failure decompensation. Supplemental oxygen therapy may be required. Learn more about evidence-based guidelines for managing acute exacerbations of bronchiectasis and explore how S10.AI can support personalized treatment plans for complex patient populations.
What are the best practices for long-term monitoring and follow-up care for patients with non-cystic fibrosis bronchiectasis to prevent disease progression and improve quality of life?+
Long-term management of non-cystic fibrosis bronchiectasis focuses on optimizing airway clearance, preventing and treating infections, and managing comorbidities. Regular follow-up appointments are essential to assess disease activity, adjust treatment plans, and monitor lung function. Encourage patients to adhere to daily airway clearance techniques and pulmonary rehabilitation. Vaccinations against influenza and pneumococcus are crucial for preventing infections. Consider implementing strategies for early detection and treatment of exacerbations, which can significantly impact long-term outcomes and quality of life. Explore how S10.AI can facilitate comprehensive patient monitoring and support shared decision-making in bronchiectasis management.
Clinical accuracy: This information is provided for documentation and coding guidance and should not replace professional medical judgment.
Coding standard: ICD-10-CM, current FY guidelines.